Cancer

At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.

Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.

Find out more about:

Bill Walsh Translational Cancer Research Laboratory

Bowel Cancer and Biomarker Research Lab

Breast Cancer Research

Cancer Genetics Laboratory

Kolling Institute Tumour Bank

Events, News and Seminars

Kolling researcher honoured with prestigious, international role

Kolling researcher honoured with prestigious, international role

Congratulations to the Kolling’s Acting Executive Director Professor Chris Little following his ele..... Read more

Category: Research Excellence

Researchers offer new approach to detect frailty in older adults

Researchers offer new approach to detect frailty in older adults

A team of researchers led by the Kolling’s Professor Sarah Hilmer has developed a valuable resource ..... Read more

Category: New Treatment

Philanthropic funding brings new hope to those with chronic pain

Philanthropic funding brings new hope to those with chronic pain

Some of the nation’s leading pain experts are set to embark on research which they believe will chan..... Read more

Category: Funding support, New Treatment